Microglia signaling as a target of donepezil

Neuropharmacology

Volumn 58, Issue 7, 2010, Pages 1122-1129

  Hwang, Jaegyu ^a   Hwang, Heehong ^a   Lee, Ho Won ^a   Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Acetylcholine; Donepezil; Microglia; Neuroinflammation; Neuroprotection

Indexed keywords

DONEPEZIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NICOTINIC RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY TEST; DRUG EFFICACY; DRUG TARGETING; GENE EXPRESSION; MICROGLIA; MOUSE; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GENE EXPRESSION; INDANS; INTERLEUKIN-1BETA; MICE; MICROGLIA; NEUROIMMUNOMODULATION; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PIPERIDINES; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950930693     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.02.003     Document Type: Article

References (43)

1. Akasofu S., Kimura M., Kosasa T., Sawada K., Ogura H. Study of neuroprotection of donepezil, a therapy for Alzheimer's disease. Chem. Biol. Interact. 2008, 175:222-226.
2. Arias E., Gallego-Sandin S., Villarroya M., Garcia A.G., Lopez M.G. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J. Pharmacol. Exp. Ther. 2005, 315:1346-1353.
3. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
4. Bocchini V., Mazzolla R., Barluzzi R., Blasi E., Sick P., Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J. Neurosci. Res. 1992, 31:616-621.
5. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
6. Carnevale D., De Simone R., Minghetti L. Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol. Disord. Drug Targets 2007, 6:388-397.
7. Cheepsunthorn P., Radov L., Menzies S., Reid J., Connor J.R. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 2001, 35:53-62.
8. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 2005, 25:9275-9284.
9. D'Intino G., Paradisi M., Fernandez M., Giuliani A., Aloe L., Giardino L., Calza L. Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3070-3075.
10. De Simone R., Ajmone-Cat M.A., Carnevale D., Minghetti L. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J. Neuroinflammation 2005, 2:4.
11. Giunta B., Ehrhart J., Townsend K., Sun N., Vendrame M., Shytle D., Tan J., Fernandez F. Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Res. Bull. 2004, 64:165-170.
12. Haddad J.J., Saade N.E., Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J. Neuroimmunol. 2002, 133:1-19.
13. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
14. Hansen R.A., Gartlehner G., Webb A.P., Morgan L.C., Moore C.G., Jonas D.E. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clin. Interv. Aging 2008, 3:211-225.
15. Hwang J., Zheng L.T., Ock J., Lee M.G., Kim S.H., Lee H.W., Lee W.H., Park H.C., Suk K. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 2008, 55:826-834.
16. Kawashima K., Fujii T. The lymphocytic cholinergic system and its biological function. Life Sci. 2003, 72:2101-2109.
17. Kosasa T., Kuriya Y., Matsui K., Yamanishi Y. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. Eur. J. Pharmacol. 2000, 389:173-179.
18. Kotani S., Yamauchi T., Teramoto T., Ogura H. Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chem. Biol. Interact. 2008, 175:227-230.
19. Lee J.H., Park S.Y., Shin Y.W., Kim C.D., Lee W.S., Hong K.W. Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats. Brain Res. 2007, 1185:246-255.
20. Lee S., Lee J., Kim S., Park J.Y., Lee W.H., Mori K., Kim S.H., Kim I.K., Suk K. A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol. 2007, 179:3231-3241.
21. Lee S., Park J.Y., Lee W.H., Kim H., Park H.C., Mori K., Suk K. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 2009, 29:234-249.
22. Long-Smith C.M., Sullivan A.M., Nolan Y.M. The influence of microglia on the pathogenesis of Parkinson's disease. Prog. Neurobiol. 2009, 89:277-287.
23. Nakamura Y., Si Q.S., Kataoka K. Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide. Neurosci. Res. 1999, 35:95-100.
24. Ota, T., Shinotoh, H., Fukushi, K., Kikuchi, T., Sato, K., Tanaka, N., Shimada, H., Hirano, S., Miyoshi, M., Arai, H., Suhara, T., Irie, T. Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography. Clin. Neuropharmacol., in press.
25. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
26. Reale M., Iarlori C., Gambi F., Feliciani C., Isabella L., Gambi D. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients. Neuropharmacology 2006, 50:606-613.
27. Reale M., Iarlori C., Gambi F., Feliciani C., Salone A., Toma L., DeLuca G., Salvatore M., Conti P., Gambi D. Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. J. Neuroimmunol. 2004, 148:162-171.
28. Samochocki M., Zerlin M., Jostock R., Groot Kormelink P.J., Luyten W.H., Albuquerque E.X., Maelicke A. Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR. Acta Neurol. Scand. 2000, Suppl. 176:68-73.
29. Saura J., Tusell J.M., Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189.
30. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989, 17:6419.
31. Schubert D., Heinemann S., Carlisle W., Tarikas H., Kimes B., Patrick J., Steinbach J.H., Culp W., Brandt B.L. Clonal cell lines from the rat central nervous system. Nature 1974, 249:224-227.
32. Schwab C., McGeer P.L. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J. Alzheimers Dis. 2008, 13:359-369.
33. Seltzer B. Donepezil: a review. Expert Opin. Drug Metab. Toxicol. 2005, 1:527-536.
34. Shytle R.D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., Ehrhart J., Silver A.A., Sanberg P.R., Tan J. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J. Neurochem. 2004, 89:337-343.
35. Sochocka M., Zaczynska E., Leszek J., Siemieniec I., Blach-Olszewska Z. Effect of donepezil on innate antiviral immunity of human leukocytes. J. Neurol. Sci. 2008, 273:75-80.
36. Tabet N. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!. Age Ageing 2006, 35:336-338.
37. Takada-Takatori Y., Kume T., Ohgi Y., Izumi Y., Niidome T., Fujii T., Sugimoto H., Akaike A. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil. J. Neurosci. Res. 2008, 86:3575-3583.
38. Tyagi E., Agrawal R., Nath C., Shukla R. Effect of anti-dementia drugs on LPS induced neuroinflammation in mice. Life Sci. 2007, 80:1977-1983.
39. Tyagi E., Agrawal R., Nath C., Shukla R. Inhibitory role of cholinergic system mediated via {alpha}7 nicotinic acetylcholine receptor in LPS-induced neuro-inflammation. Innate Immun. 2010, 16:3-13.
40. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
41. Walter L., Neumann H. Role of microglia in neuronal degeneration and regeneration. Semin. Immunopathol. 2010, 31:513-525.
42. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
43. Zheng L.T., Hwang J., Ock J., Lee M.G., Lee W.H., Suk K. The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production. J. Neurochem. 2008, 107:1225-1235.